Overview

• The largest-ever meta-analysis on medical cannabis, published in Frontiers in Oncology, reviewed over 10,000 studies, finding a 75% positive consensus on its cancer-related benefits.
• The study identified cannabis as effective in alleviating symptoms such as nausea, appetite loss, and inflammation, while also suggesting potential anti-cancer properties like tumor cell death and growth inhibition.
• Researchers used AI-driven sentiment analysis to categorize studies, overcoming biases and establishing a comprehensive view of cannabis’s role in oncology.
• The study’s authors are calling for the DEA to reclassify cannabis from Schedule I to enable large-scale human clinical trials and further validate its therapeutic potential.
• While some oncologists acknowledge cannabis’s symptom management benefits, skepticism remains regarding its ability to directly cure cancer without more robust clinical evidence.